This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
fin-tech: Archive
These Banking Stocks are Set to Flourish Despite the Banking Crisis
by Andrew Rocco
Though a banking crisis may be daunting for investors, the storm will pass, and strong stocks will benefit dramatically. Industry consolidation, shrinking valuations, and innovation should provide investors ample opportunity.
AMZNNegative Net Change GSNegative Net Change JPMPositive Net Change AAPLPositive Net Change COFNegative Net Change FCNCAPositive Net Change HSBCNegative Net Change SQPositive Net Change
fin-tech finance investing large-cap
Colgate-Palmolive (CL) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
CLNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Vulcan Materials (VMC) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
VMCNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Yeti (YETI) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
YETINegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
After Golden Cross, Splash Beverage Group, Inc. (SBEV)'s Technical Outlook is Bright
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
SBEVNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy ImmunoGen (IMGN) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
IMGNPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Best Growth Stocks to Buy for May 11th
by Zacks Equity Research
FOUR, PHM and PERI made it to the Zacks Rank #1 (Strong Buy) growth stocks list on May 11, 2023.
PHMNegative Net Change PERINegative Net Change FOURPositive Net Change
fin-tech
Should You Buy Bellus Health (BLU) After Golden Cross?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
DaVita HealthCare (DVA)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
DVANegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Orchard Therapeutics PLC Sponsored ADR (ORTX) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
ORTXPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
PayPal Earnings Review: A Strong Quarter, but Highly Competitive Industry
by Ethan Feller
PayPal Earnings Review: A Strong Quarter, but Highly Competitive Industry
BACNegative Net Change JPMPositive Net Change AAPLPositive Net Change MANegative Net Change VNegative Net Change GOOGLPositive Net Change PYPLNegative Net Change SQPositive Net Change
fin-tech payments
Sea Limited Earnings Preview: Risky but Huge Potential
by Ethan Feller
SE has an ecommerce, online gaming, and digital payments business focused on the Southeast Asian region
SENegative Net Change MELIPositive Net Change
e-commerce fin-tech gaming tech-stocks
Time to Invest in the Growth of FinTech?
by Shaun Pruitt
Currently valued at upwards of $200 billion, it would be no surprise if the fintech market becomes a trillion-dollar industry in the distant future as innovation continues among financial services.
MANegative Net Change VNegative Net Change PYPLNegative Net Change SQPositive Net Change AMZNNegative Net Change EBAYNegative Net Change
banking bitcoin cryptocurrency e-commerce fin-tech finance internet investing large-cap payments software stock-performance tech-stocks
The Zacks Analyst Blog Highlights American Express, Enbridge, Micron Technology, Old Dominion Freight Line and Nordson
by Zacks Equity Research
American Express, Enbridge, Micron Technology, Old Dominion Freight Line and Nordson are included in this Analyst Blog.
AXPNegative Net Change MUPositive Net Change ENBPositive Net Change ODFLNegative Net Change NDSNNegative Net Change
fin-tech
Zacks Investment Ideas feature highlights: Global X MSCI Argentina ETF, iShares MSCI Mexico ETF, StoneCo, Paypal and MercadoLibre
by Zacks Equity Research
Global X MSCI Argentina ETF, iShares MSCI Mexico ETF, StoneCo, Paypal and MercadoLibre have been highlighted in this Investment Ideas article.
MELIPositive Net Change PYPLNegative Net Change ARGTNegative Net Change EWWPositive Net Change STNEPositive Net Change
fin-tech
Visa and Mastercard Earnings: Time to Buy?
by Ethan Feller
Visa V and Mastercard MA are two of the steadiest performing stocks in the market
MANegative Net Change VNegative Net Change
earnings fin-tech
Bear of the Day: Black Knight, Inc. (BKI)
by Bryan Hayes
Negative year-over-year growth along with falling future estimates signal caution ahead.
BKINegative Net Change
business-services earnings fin-tech home-buying-apps investing real-estate software
Should You Buy Consolidated Edison (ED) After Golden Cross?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
EDNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Don't Overlook These 2 Finance Innovators It's Time to Buy
by Shaun Pruitt
Keeping in mind that Fiserv (FISV) and Interactive Brokers (IBKR) stocks have both skyrocketed over +400% in the last decade makes their continued expansion very intriguing.
IBKRPositive Net Change FISVPositive Net Change
fin-tech finance investing payments
5 U.S. Giants Set to Beat on Q1 Earnings Next Week
by Nalak Das
We have narrowed our search to five U.S. corporate bigwigs that are set to report first-quarter 2023 earnings results next week. These are: BK, TSLA, DFS, STT and NDAQ.
NDAQNegative Net Change BKPositive Net Change STTNegative Net Change TSLAPositive Net Change
auto-tires-trucks fin-tech finance
How to Best Navigate the Ship Through This Choppy Market Environment
by Bryan Hayes
Numerous tailwinds for stocks can help push this rally further.
SENegative Net Change
e-commerce earnings emerging-markets fin-tech inflation interest-rate internet investing payments software tech-stocks
Best Value Stocks to Buy for April 12th
by Zacks Equity Research
MGI made it to the Zacks Rank #1 (Strong Buy) value stocks list on April 12, 2023.
MGIPositive Net Change
fin-tech
Should You Buy Lululemon (LULU) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
LULUNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Endeavour Silver (EXK) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
EXKNo Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
The Zacks Analyst Blog Highlights Mastercard, AstraZeneca, Philip Morris, TJX and Citigroup
by Zacks Equity Research
Mastercard, AstraZeneca, Philip Morris, TJX and Citigroup are included in this Analyst Blog.
CPositive Net Change AZNNegative Net Change MANegative Net Change TJXNegative Net Change PMNegative Net Change
fin-tech